Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2882-21-5

Post Buying Request

2882-21-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2882-21-5 Usage

Description

2-Methoxy-6-methylpyrazine is an organic compound that belongs to the pyrazine family. It is known for its distinct aroma and is commonly found in sherry and krill. 2-methoxy-6-methylpyrazine has a nut-like flavor profile, reminiscent of hazelnut, almond, and peanut, making it a popular choice as a flavoring agent for various food and beverage products. Its chemical structure features a methoxy group at the 2nd position and a methyl group at the 6th position, which contribute to its unique properties and applications.

Uses

Used in Flavor and Fragrance Industry:
2-Methoxy-6-methylpyrazine is used as a flavoring agent for imparting nut-like aroma to foods and beverages. Its ability to mimic the scent of hazelnuts, almonds, and peanuts makes it a valuable ingredient in the creation of various food products, enhancing their taste and appeal to consumers.
Used in Coffee Industry:
As a coffee aroma enhancing agent, 2-methoxy-6-methylpyrazine is utilized to improve the overall aroma and flavor profile of coffee beverages. Its addition can elevate the sensory experience of coffee, making it more enjoyable for consumers.
Used in Pharmaceutical Industry:
2-Methoxy-6-methylpyrazine can be used for drug storage packaging, specifically for storing antiviral and antibacterial medications. Its presence in the packaging material can help maintain the stability and effectiveness of these medications, ensuring their potency and safety for use.
Aroma Threshold Values:
The detection threshold for 2-methoxy-6-methylpyrazine is relatively low, ranging from 3 to 7 parts per billion (ppb). This indicates that even trace amounts of the compound can be perceived by the human olfactory system, highlighting its potency as a flavoring agent and its importance in the flavor and fragrance industry.

Preparation

From 2-methylpyrazine by various routes.

Check Digit Verification of cas no

The CAS Registry Mumber 2882-21-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,8,8 and 2 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 2882-21:
(6*2)+(5*8)+(4*8)+(3*2)+(2*2)+(1*1)=95
95 % 10 = 5
So 2882-21-5 is a valid CAS Registry Number.
InChI:InChI=1/C6H8N2O/c1-5-3-7-4-6(8-5)9-2/h3-4H,1-2H3

2882-21-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-methoxy-6-methylpyrazine

1.2 Other means of identification

Product number -
Other names 2-Methyl-6-methoxypyrazine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2882-21-5 SDS

2882-21-5Downstream Products

2882-21-5Relevant articles and documents

COMBINATION TREATMENTS COMPRISING IMIDAZOPYRAZINONES FOR THE TREATMENT OF PSYCHIATRIC AND/OR COGNITIVE DISORDERS

-

Page/Page column 48-49, (2018/05/24)

The present invention provides combination treatments comprising administration of compounds that are PDE1 enzyme inhibitors and other compounds useful in the treatment of psychiatric and/or cognitive disorders such as for example Attention Deficit Hyperactivity Disorder (ADHD), depression, anxiety, narcolepsy, schizophrenia, cognitive impairment or cognitive impairment associated with schizophrenia (CIAS). Separate aspects of the invention are directed to the combined use of said compounds for the treatment of psychiatric and/or cognitive disorders. The present invention also provides pharmaceutical compositions comprising said PDE1 enzyme inhibitors together with other compounds useful in the treatment of psychiatric and/or cognitive disorders.

IMIDAZOPYRAZINONES AS PDE1 INHIBITORS

-

Page/Page column 47; 48, (2016/11/17)

The present invention provides imidazopyrazinones as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2882-21-5